If you or a loved one have high triglycerides and are at risk for a cardiovascular event, new options may be available.
This trial is testing whether an investigational drug, Epanova (omega-3 fatty acids), can reduce the risk of serious heart problems when taken in combination with a statin. Epanova is already FDA-approved to treat patients with severely high triglycerides.
You or your loved one may be able to take part if you or he/she:
-Are at least 18 years of age;
-Are currently taking a statin;
-Have a low HDL cholesterol level (less than 42 for men, less than 47 for women)
-Have a current triglycerides level of 180-500;
-Are at risk for MACE (major adverse cardiovascular events, such as heart attack or stroke)